Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro

Non-alcoholic fatty liver disease (NAFLD) causes liver dysfunction and is associated with obesity and type 2 diabetes. Chronic inflammation is associated not only with the development of NAFLD, but also with hepatic diseases, including steatohepatitis, cirrhosis, and hepatocellular carcinoma. Aurano...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antioxidants (Basel)
Hauptverfasser: Hwangbo, Hyun, Kim, Min Yeong, Ji, Seon Yeong, Kim, So Young, Lee, Hyesook, Kim, Gi-Young, Park, Cheol, Keum, Young-Sam, Hong, Su Hyun, Cheong, Jaehun, Choi, Yung Hyun
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7690872/
https://ncbi.nlm.nih.gov/pubmed/33114221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox9111040
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge